Pulmonary embolism associated with intravenous immunoglobulin therapy [1]

Annals of Pharmacotherapy

Volumn 37, Issue 10, 2003, Pages 1530-

  Butler, Katasha S ^a   Zeitlin, Deborah S ^b  

^a BUTLER UNIVERSITY   (United States)

^b Podiatry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ENOXAPARIN; IMMUNOGLOBULIN; OXYCODONE; PARACETAMOL; WARFARIN;

ABDOMINAL PAIN; ADULT; ANAMNESIS; ANAPHYLAXIS; ANXIETY DISORDER; CASE REPORT; CHILL; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DRUG MEGADOSE; DYSPNEA; FEVER; HEADACHE; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; IMMUNOTHERAPY; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; LETTER; LUNG EMBOLISM; MALE; NAUSEA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RISK FACTOR; THORAX PAIN; THROMBOSIS;

EID: 0141781198     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D037L     Document Type: Letter

References (5)

1. Steg RE, Lefkowitz DM. Cerebral infarction following intravenous immunoglobulin therapy for myasthenia gravis. Neurology 1994;44:1180-1.
2. Alliot C, Rapin JP, Besson M, Bedjaoui F, Messouak D. Pulmonary embolism after intravenous immunoglobulin. J R Soc Med 2001;94:187-8.
3. Ryan ME, Webster ML, Statler JD. Adverse effects of intravenous immunoglobulin therapy. Clin Pediatr (Phila) 1996;35:23-31.
4. Reinhart RH, Berchtold PE. Effect of high-dose intravenous immunoglobulin therapy on blood rheology. Lancet 1992;339:662-4.
5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.